Beximco Pharmaceuticals Limited (AIM: BXP)
London flag London · Delayed Price · Currency is GBP · Price in GBX
37.70
+1.20 (3.29%)
Dec 20, 2024, 8:13 AM GMT+1

Beximco Pharmaceuticals Company Description

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh.

The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.

It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids.

The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

Beximco Pharmaceuticals Limited
Country Bangladesh
Founded 1976
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,122
CEO Iqbal Ahmed

Contact Details

Address:
19 Dhanmondi R/A
Dhaka, 1205
Bangladesh
Phone 880 2 5861 1001
Website beximcopharma.com

Stock Details

Ticker Symbol BXP
Exchange London Stock Exchange AIM
Fiscal Year July - June
Reporting Currency BDT
ISIN Number US0885792061
SIC Code 2834

Key Executives

Name Position
Iqbal Ahmed Chief Executive Officer
Mohammad Nawaz Chief Financial Officer
S. M. Reza Chief Operating Officer